J and j stock buy or sell? (2024)

J and j stock buy or sell?

Johnson & Johnson has a conensus rating of Moderate Buy which is based on 7 buy ratings, 6 hold ratings and 0 sell ratings. The average price target for Johnson & Johnson is $178.08. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.

(Video) Johnson & Johnson AAA Rated 3% Dividend Yield Good Value: Buy, Sell or Hold? | FAST Graphs
(FASTgraphs)
Where will JNJ stock be in 5 years?

Johnson & Johnson stock price stood at $161.68

According to the latest long-term forecast, Johnson & Johnson price will hit $200 by the end of 2026 and then $250 by the end of 2028. Johnson & Johnson will rise to $300 within the year of 2030 and $350 in 2033.

(Video) Is This Dividend Stock a BUY Right Now? || Johnson & Johnson (JNJ)
(The Average Joe Investor)
What is the target price for J stock?

Jacobs Solutions Inc (NYSE:J)

The 11 analysts offering 12-month price forecasts for Jacobs Solutions Inc have a median target of 151.00, with a high estimate of 176.00 and a low estimate of 137.00. The median estimate represents a +12.80% increase from the last price of 133.87.

(Video) 10 Reasons to Buy Johnson & Johnson (JNJ) Stock in 2023 | Johnson & Johnson Stock Analysis
(Simple Investing Secrets)
Is JNJ overvalued or undervalued?

The intrinsic value of one JNJ stock under the Base Case scenario is 155.41 USD. Compared to the current market price of 160.78 USD, Johnson & Johnson is Overvalued by 3%.

(Video) How to Value Dividend Stocks [JNJ Stock 2022]
(Nathan Winklepleck, CFA)
What is the stock price prediction for JNJ tomorrow?

The Johnson & Johnson stock forecast for tomorrow is $ 159.04, which would represent a -0.79% loss compared to the current price. In the next week, the price of JNJ is expected to decrease by -1.22% and hit $ 158.34.

(Video) Is Johnson and Johnson Stock a Buy Now!? | Johnson and Johnson (JNJ) Stock Analysis! |
(Dividendology)
Is JNJ going to split into two companies?

Why Johnson & Johnson is splitting itself into two publicly traded companies. Johnson & Johnson, the biggest pharmaceutical company in the U.S. based on market cap, announced in November 2021 it plans to spin off its consumer business into a new publicly traded company by November 2023.

(Video) A JNJ Stock Analysis and Review
(Nanalyze)
Will JNJ stock go back up?

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Johnson & Johnson have a median target of 175.00, with a high estimate of 215.00 and a low estimate of 157.00. The median estimate represents a +8.25% increase from the last price of 161.67.

(Video) Johnson & Johnson ($JNJ) & TSMC ($TSM) JUST REPORTED EARNINGS | Stock Market Today
(Everything Money)
Is J and Ja good long term stock?

Johnson & Johnson is still a top pick for investors looking for a stable company whose dividend is safe. And while it is essential to monitor how its legal challenges develop, the company's stock is a buy regardless.

(Video) The AI Bubble is About To Pop & CRASH the Markets - Investors Are Extremely Complacent
(Ron Walker)
What will JNJ stock be worth in 2030?

Johnson and Johnson stock prediction

The site said the JNJ share prices could exceed $250 next year, with an average price of $269.53 in 2023, $259.94 in 2024, $267.41 in 2025, $267.92 in 2026, $262.98 in 2027, $246.29 in 2028, $230.15 in 2029 and $197.04 in 2030.

(Video) (URGENT!) Look At This Before Tuesday Stock Market Open! - apple tesla meta nvda sp500 nasdaq qqq
(NASDAQ KING)
What is the stock price forecast for JNJ in 12 months?

What is JNJ's average 12-month price target, according to analysts? Based on analyst ratings, Johnson & Johnson's 12-month average price target is $178.08.

(Video) NEW RECORD: Stocks Just Peaked | DO THIS NOW!
(Andrei Jikh)

Is JNJ a safe investment?

Overall, Johnson & Johnson stock has a Value Grade of F, Growth Grade of A, Quality Grade of A, Momentum Grade of C . Whether or not you should buy Johnson & Johnson stock will ultimately depend on your individual goals, risk tolerance and allocation.

(Video) EVERYTHING MONEY on JOHNSON & JOHNSON ($JNJ STOCK) ARE THEY RIGHT?
(Financially Fit )
How safe is JNJ stock?

Johnson & Johnson is a safe investment option with a history of consistent income and extreme financial safety. JNJ's recent performance, positive business developments, and long-term growth prospects make it a compelling investment for conservative investors.

J and j stock buy or sell? (2024)
Why is JNJ stock so low?

The sprawling litigation over its talc products, in particular, took a turn for the worse in late July. Still, much of the drop likely stems from a broader malaise that's afflicted pharmaceutical and medical device stocks this year. More than one malady has struck the healthcare sector, and there's no panacea in sight.

What is the future growth of JNJ?

Over the five years through 2030, Johnson & Johnson said it expects compound annual sales growth of 5% to 7%, including at least 3% operational sales growth in 2025 despite the entry into the U.S. of a Stelara biosimilar.

Why did JNJ stock go up?

It Lifts Guidance in First Post-Kenvue Earnings. Johnson & Johnson raised its full-year financial guidance as it reported its first results since splitting off its consumer health division. The brighter outlook accompanied third-quarter earnings that beat Wall Street expectations.

Is Coca Cola a buy or sell?

Is Coca-Cola stock a Buy, Sell or Hold? Coca-Cola stock has received a consensus rating of buy. The average rating score is A1 and is based on 37 buy ratings, 10 hold ratings, and 0 sell ratings.

Will JNJ shareholders receive shares of Kenvue?

What does the J&J split mean for shareholders? If you currently own shares of Johnson & Johnson, when the company splits, you will own shares of both Johnson & Johnson – which will be the new pharmaceutical/medical device business – as well as shares of Kenvue, the new consumer health business.

What happens to JNJ stock after spinoff?

What happens to JNJ stock when the company splits? Once Johnson and Johnson splits, JNJ stock will only give traders and investors exposure to the medical device and pharmaceutical proceeds of the company. The new company, which will be listed as Kenvue, will trade separately.

Who owns the most shares of JNJ?

Largest shareholders include Vanguard Group Inc, BlackRock Inc., State Street Corp, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, VFINX - Vanguard 500 Index Fund Investor Shares, Geode Capital Management, Llc, Morgan Stanley, State Farm Mutual Automobile Insurance Co, Jpmorgan Chase & Co, and Northern ...

Is Johnson and Johnson profitable?

Johnson & Johnson gross profit for the twelve months ending September 30, 2023 was $66.515B, a 6.25% increase year-over-year. Johnson & Johnson annual gross profit for 2022 was $63.854B, a 0.1% decline from 2021. Johnson & Johnson annual gross profit for 2021 was $63.92B, a 18.03% increase from 2020.

Is Walmart stock expected to go up?

The 30 analysts with 12-month price forecasts for Walmart stock have an average target of 178.83, with a low estimate of 163 and a high estimate of 210. The average target predicts an increase of 10.13% from the current stock price of 162.38. * Price targets were last updated on Nov 17, 2023.

What is the forecast for Apple stock?

Stock Price Forecast

The 38 analysts offering 12-month price forecasts for Apple Inc have a median target of 200.00, with a high estimate of 250.00 and a low estimate of 125.00. The median estimate represents a +4.41% increase from the last price of 191.56.

What's the best stock to buy and hold forever?

7 Dividend Stocks to Buy and Hold Forever
StockImplied upside from Dec. 29 CloseForward dividend yield
Procter & Gamble Co. (PG)18.7%2.6%
AbbVie Inc. (ABBV)27.1%4.4%
Coca-Cola Co. (KO)10.3%3.1%
McDonald's Corp. (MCD)6.2%2.3%
3 more rows

What are the safest stocks to buy long term?

7 of the Best Long-Term Stocks to Buy
StockSectorMarket Cap
Consolidated Edison Inc. (ED)Utilities$31 billion
Johnson & Johnson (JNJ)Health care$374 billion
JPMorgan Chase & Co. (JPM)Financial$484 billion
Prologis Inc. (PLD)Real estate$122 billion
3 more rows

Is Amazon a buy or sell?

Amazon's analyst rating consensus is a Strong Buy. This is based on the ratings of 41 Wall Streets Analysts.

You might also like
Popular posts
Latest Posts
Article information

Author: Kimberely Baumbach CPA

Last Updated: 02/04/2024

Views: 6752

Rating: 4 / 5 (61 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Kimberely Baumbach CPA

Birthday: 1996-01-14

Address: 8381 Boyce Course, Imeldachester, ND 74681

Phone: +3571286597580

Job: Product Banking Analyst

Hobby: Cosplaying, Inline skating, Amateur radio, Baton twirling, Mountaineering, Flying, Archery

Introduction: My name is Kimberely Baumbach CPA, I am a gorgeous, bright, charming, encouraging, zealous, lively, good person who loves writing and wants to share my knowledge and understanding with you.